Executive Summary
AI
- Michael Schmidt of the Medical University of South Carolina hosts this October 16th, 2025 episode of TWIM with Mark Martin of the University of Puget Sound pinch hitting while Vincent, Petra and Michelle travel.0:34
- The episode covers two open access papers from the October 1st issue of Nature: the Panoptes system, a two-gene defence in which OptS constantly makes 2'3' cyclic diAMP to keep the membrane-disrupting effector OptE switched off.3:08
- When a phage brings in its sponge protein ACB2 to soak up the signal, OptE is released, collapses the membrane and aborts the infection — and 14 out of the 15 phage escapers found had loss of function mutations in ACB2, showing the sponge is required to trigger the system.11:15
- The second paper, from the Duna lab, reached the same conclusion in E. coli using CRISPR interference against ACB1, ACB2 and ACB4, naming the polymerase MC-PAL and the effector 2TM beta, with crystal structures explaining why the enzyme is always active.19:58
- Schmidt and Martin close on what this means for phage therapy and antibiotic resistance, with Panoptes presenting phage an impossible choice between keeping their anti-CBAS tools and being killed by Panoptes or ditching them and being killed by CBAS.34:38
Key Quote
“And no matter what trick we came up with, the microbes always seem to outsmart the humans.”
— Michael Schmidt6:15
Key Quote
“Now, publishing back-to-back like this is the scientific equivalent of two sprinters crushing the finish line in a photo finish.”
— Michael Schmidt20:56
Key Quote
“Panoptis doesn't detect the phage directly. It detects the phage's attempt at immune evasion.”
— Michael Schmidt34:03